texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

CAR-T Therapy

Chimeric Antigen Receptor – T cell (CAR-T) therapy is one of the most exciting, promising treatment breakthroughs in recent years. Texas Oncology is one of the very few authorized centers in the country to initially provide CAR-T therapy.

A type of immunotherapy, CAR-T therapy galvanizes the body’s immune system to fight cancer. It uses genetically engineered immune T cells to recognize specific proteins on tumor cells. Some of a patient’s white blood cells are extracted, modified, and replicated so that they recognize and attack cancer cells. Learn more about how CAR-T works.

Eligible Patients

CAR-T provides another treatment option when standard treatments are not effective. Adult patients with relapsed or refractory large B-cell lymphoma, a type of non-Hodgkin lymphoma, and who have failed two or more types to therapy may be eligible. CAR-T clinical trials may be available for other hematologic malignancies or solid tumors.

Request an Appointment or More Information

Patients interested in CAR-T therapy should call 214-370-1999.

Eligible patients are treated at Texas Oncology-Charles A. Sammons Cancer Center in Dallas. Telemedicine consults are available.

Available Physicians

Texas Oncology-Charles A. Sammons Cancer Center physicians offering CAR-T therapy are:

Edward Agura, M.D.
Robert Brian Berryman, M.D.
Micah Burch, M.D.
Carolina Escobar, M.D.
Houston Holmes, M.D.
M. Yair Levy, M.D.
Christopher Maisel, M.D.
Edward James Pearson, M.D.
Luis Pineiro, M.D.
Jana Reynolds, M.D.
Estil Vance, M.D.
Andrew Robert Whiteley, M.D.